Literature DB >> 16107038

Selected topics in probiotics and prebiotics: meeting report for the 2004 international scientific association for probiotics and prebiotics.

Mary Ellen Sanders1, Francisco Guarner, David Mills, Bruno Pot, Joseph Rafter, Bob Rastall, Gregor Reid, Yehuda Ringel, Ian Rowland, Maria Saarela, Kieran Tuohy.   

Abstract

On August 29-31, 2004, 84 academic and industry scientists from 16 countries gathered in Copper Mountain, Colorado USA to discuss certain issues at the forefront of the science of probiotics and prebiotics. The format for this invitation only meeting included six featured lectures: engineering human vaginal lactobacilli to express HIV-inhibitory molecules (Peter Lee, Stanford University), programming the gut for health (Thaddeus Stappenbeck, Washington University School of Medicine), immune modulation by intestinal helminthes (Joel Weinstock, University of Iowa Hospitals and Clinics), hygiene as a cause of autoimmune disorders (G. A. Rook, University College London), prebiotics and bone health (Connie Weaver, Purdue University) and prebiotics and colorectal cancer risk (Ian Rowland, Northern Ireland Centre for Food and Health). In addition, all participants were included in one of eight discussion groups on the topics of engineered probiotics, host-commensal bacteria communication, 'omics' technologies, hygiene and immune regulation, biomarkers for healthy people, prebiotic and probiotic applications to companion animals, development of a probiotic dossier, and physiological relevance of prebiotic activity. Brief conclusions from these discussion groups are summarized in this paper.

Entities:  

Mesh:

Year:  2005        PMID: 16107038

Source DB:  PubMed          Journal:  Curr Issues Intest Microbiol        ISSN: 1466-531X


  2 in total

1.  Probiotics to prevent the need for, and augment the use of, antibiotics.

Authors:  Gregor Reid
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

2.  Multicopy integration of heterologous genes, using the lactococcal group II intron targeted to bacterial insertion sequences.

Authors:  Helen Rawsthorne; Kevin N Turner; David A Mills
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.